Asherman Syndrome

What Is Asherman Syndrome?

Asherman syndrome is a rare but significant disorder of the uterus characterized by the formation of scar tissue (intrauterine adhesions) within the uterine cavity. These adhesions can partially or completely block the inside of the uterus, leading to menstrual disturbances, pain, infertility, or pregnancy complications. Asherman syndrome most commonly arises after trauma to the uterine lining, such as from a surgical procedure like dilation and curettage (D&C), but it can also result from infection or other uterine interventions.

In clinical practice, Asherman syndrome is diagnosed when a person who has previously had normal periods develops reduced menstrual flow, no periods (amenorrhea), or secondary infertility, and imaging or hysteroscopic evaluation reveals intrauterine adhesions. Understanding and treating this condition is important for people trying to conceive, as it can have profound effects on uterine health and fertility.

Key Takeaways

Asherman syndrome refers to scar tissue (intrauterine adhesions) that forms inside the uterus, often after uterine surgery or infection.
The main symptoms include menstrual changes, such as lighter periods or amenorrhea, pelvic pain, and infertility.
The diagnosis is confirmed using imaging, especially hysteroscopy, which allows direct visualization and treatment of adhesions.
The leading cause is trauma to the uterine lining, with D&C after miscarriage or birth being the most common trigger.
Treatment usually involves hysteroscopic adhesiolysis, a minimally invasive surgical procedure to remove adhesions.
Asherman syndrome can impact fertility by preventing implantation or increasing miscarriage risk.
Recurrence is possible, especially in severe cases, so follow-up and sometimes preventive therapies are needed.
Many people with mild or moderate Asherman syndrome can regain fertility after successful treatment.
Early diagnosis and management are crucial for optimizing reproductive outcomes.
Support from fertility specialists (REI) is recommended for anyone diagnosed with or suspected of having Asherman syndrome.

What Is Asherman Syndrome?
What Causes Asherman Syndrome?
How Does Asherman Syndrome Affect Fertility and Reproductive Health?
What Are the Symptoms of Asherman Syndrome?
How Is Asherman Syndrome Diagnosed?
What Does Treatment for Asherman Syndrome Involve?
Risks, Recurrence, and Preventive Strategies
What Is the Prognosis for Fertility After Treatment?
Quick Facts Table: Asherman Syndrome
Myths vs. Facts About Asherman Syndrome
Frequently Asked Questions About Asherman Syndrome
When to Consult a Specialist
References and Further Reading
Disclaimer

What Causes Asherman Syndrome?

Asherman syndrome is primarily caused by trauma to the endometrium (the inner lining of the uterus), which leads to the formation of scar tissue or adhesions. The most common cause is a surgical procedure called dilation and curettage (D&C), which is often performed after a miscarriage, abortion, or for the removal of retained pregnancy tissue. The risk of developing adhesions is highest when D&C is performed in the context of pregnancy or infection.

Other known causes include:

Repeated uterine surgeries: Multiple D&Cs or uterine interventions increase risk.
Uterine infections: Postpartum or post-abortion infections, especially tuberculosis in endemic areas.
Surgical treatment for uterine fibroids or polyps.
Cesarean section: Rarely, scarring may occur after C-section or other uterine surgeries.
Radiation therapy: In rare cases, can cause intrauterine adhesions.

Key Point: Not everyone who undergoes a D&C will develop Asherman syndrome, but the risk increases with repeated procedures, infection, or performing D&C soon after childbirth or miscarriage.

Intrauterine Adhesions vs. Asherman Syndrome

While intrauterine adhesions refer to any scar tissue bands within the uterine cavity, Asherman syndrome is typically reserved for cases severe enough to cause symptoms like abnormal periods, infertility, or pregnancy loss.

How Does Asherman Syndrome Affect Fertility and Reproductive Health?

Asherman syndrome can have a major impact on reproductive health, menstrual function, and the chances of conception and a healthy pregnancy. These effects depend on:

Extent and location of adhesions: More severe or widespread scarring can cause more pronounced symptoms and complications.
Obstruction of menstrual flow: Dense adhesions can block blood from exiting the uterus, leading to lighter periods or amenorrhea and sometimes cyclical pelvic pain.
Impaired endometrial healing and function: Scar tissue can prevent the endometrial lining from growing and shedding normally, reducing its ability to support embryo implantation.
Infertility and increased risk of miscarriage: When the uterine cavity is partially or fully sealed, sperm may not reach the egg, embryos may not implant, or pregnancies may end in early loss.
Pregnancy complications: Retained placenta, abnormal placental attachment (placenta accreta), recurrent pregnancy loss, and preterm birth are more common in people with untreated or severe Asherman syndrome.

Did you know? Even after resection of adhesions, the endometrium may not fully regenerate in some people, which can impact long-term fertility outcomes.

What Are the Symptoms of Asherman Syndrome?

The symptoms of Asherman syndrome can vary widely and sometimes may be subtle or mistaken for other reproductive issues. The most common Asherman syndrome symptoms include:

Changes in menstrual flow: Lighter periods (hypomenorrhea), periods stop entirely (secondary amenorrhea), or irregular menses after previous normal cycles.
Pelvic pain or cramping: Often cyclical, corresponding to times when periods would be expected.
Recurrent miscarriage: Multiple early pregnancy losses without another clear cause.
Infertility: Difficulty conceiving after previously normal cycles.
Unexplained pregnancy complications: Such as abnormal placental attachment or retained placenta after delivery.
Asymptomatic cases: Some cases are only discovered during fertility evaluation, as not all people experience obvious symptoms.

Symptom Timeline

Symptoms typically develop weeks to months after uterine surgery or infection but may not be recognized until a person is evaluated for infertility or absent periods.

How Is Asherman Syndrome Diagnosed?

Diagnosing Asherman syndrome involves a combination of clinical assessment, history taking, and specialized imaging techniques.

Clinical Clues

History of uterine surgery or infection: Especially D&C for miscarriage, abortion, or retained products of conception.
Secondary menstrual changes: Onset of lighter or absent periods after previous regular cycles.

Diagnostic Tools

Transvaginal Ultrasound
- May detect an abnormally small (synechial) uterine cavity or missing endometrial stripe, but is not definitive.
Hysterosalpingography (HSG)
- X-ray study following the injection of dye into the uterus; can show areas where dye does not fill due to adhesions.
Sonohysterogram (Saline Infusion Sonography)
- Ultrasound with saline injected to outline internal contours; can help detect cavities or scarring.
Hysteroscopy (Gold Standard)
- Direct visualization of the uterine cavity using a specialized camera. This is the most accurate way to diagnose intrauterine adhesions and allows for simultaneous treatment.

Key Point: Hysteroscopy is the gold standard for both diagnosis and treatment of Asherman syndrome.

Differential Diagnosis

Asherman syndrome should be distinguished from other causes of amenorrhea or infertility, such as:

Polycystic ovary syndrome (PCOS)
Hypothalamic amenorrhea
Premature ovarian insufficiency
Outflow tract obstructions (cervical stenosis, vaginal septum)

What Does Treatment for Asherman Syndrome Involve?

Hysteroscopic adhesiolysis is the mainstay of Asherman syndrome treatment. This minimally invasive surgical procedure involves using a hysteroscope (a thin, lighted tube) to visualize and gently remove adhesions inside the uterus.

Steps in Treatment

Preoperative Assessment
- Imaging to define extent and location of adhesions.
Hysteroscopic Adhesiolysis
- Direct removal or cutting of scar tissue bands with fine instruments under visual guidance.
Restoring Uterine Cavity
- Care is taken to avoid further endometrial trauma.
Prevention of Re-Adhesion
- Strategies may include:
  - Placement of a balloon catheter or IUCD (intrauterine device) to keep cavity open.
  - Short course of high-dose estrogen therapy to promote endometrial healing and regeneration.
  - Repeat hysteroscopy to check for recurrent adhesions.

Table: Common Preventive Measures After Surgery

Preventive Measure	Description	Evidence Strength
Balloon catheter	Physically keeps uterine walls apart	Moderate
High-dose estrogen	Stimulates endometrial growth	Moderate-Strong
Antibiotics	Reduces risk of infection	Weak-Mixed
Repeat hysteroscopy	Detects and removes recurrent adhesions	Strong

Did you know? Occasionally, multiple hysteroscopic procedures may be needed for severe or recurrent adhesions.

Other Treatments

Treatment of Infections: If underlying or associated infection is present.
Surgical correction of anatomical abnormalities: In rare or complex cases.

Risks, Recurrence, and Preventive Strategies

Despite optimal treatment, Asherman syndrome recurrence can still occur—especially after severe, diffuse adhesions.

Risk of Recurrence

Recurrence rates vary from 3% to over 20% depending on:
- Severity of initial adhesions
- Underlying cause (infection vs. trauma)
- Adherence to preventive strategies

Strategies to Minimize Recurrence

Careful technique during hysteroscopic adhesiolysis.
Postoperative estrogen therapy and/or balloon stenting.
Early follow-up hysteroscopy for high-risk cases.

Risk Factor	Way to Reduce the Risk
Multiple D&Cs	Limit unnecessary uterine procedures
Infection	Prompt antibiotic treatment
Extensive adhesions	Careful, staged removal + surveillance
Delayed follow-up	Early re-evaluation and intervention

Key Point: Recurrence risk is lowest when Asherman syndrome is treated early and with modern minimally invasive techniques.

What Is the Prognosis for Fertility After Treatment?

The outlook for fertility after Asherman syndrome treatment depends on several factors:

Severity of adhesions prior to treatment
Ability to fully restore uterine cavity anatomy
Postoperative endometrial regeneration

Success Rates

Mild to moderate cases: Up to 70–80% will resume normal periods and have restored fertility potential Asherman syndrome review.
Severe cases: Ongoing menstrual issues and reduced pregnancy rates may persist.
Pregnancy outcome improvements: Increased live birth rates after successful adhesiolysis, but higher risks of placental complications, miscarriage, or preterm birth compared to the general population.

IVF and Asherman Syndrome

IVF may be considered if natural conception does not occur after uterine cavity restoration.
IVF success depends greatly on endometrial function; if scarring is extensive and endometrium cannot regenerate, even IVF may be challenging Fertility and Sterility review.

Quick Facts Table: Asherman Syndrome

Aspect	Description
Definition	A disorder characterized by intrauterine adhesions/scar tissue
Main Causes	Trauma to endometrium (D&C, infection, uterine surgery)
Main Symptoms	Menstrual changes, infertility, recurrent miscarriage
Gold-standard Diagnosis	Hysteroscopy
Primary Treatment	Hysteroscopic adhesiolysis
Preventive Measures	Balloon catheter, estrogen therapy, antibiotics
Fertility Impact	Can cause infertility and pregnancy complications
Prognosis	Good in mild cases; more guarded in severe or recurrent cases
Recurrence	Occurs in up to 20%, especially after severe initial disease
Specialists Involved	REI (fertility specialist), OB/GYN

Myths vs. Facts About Asherman Syndrome

Myth	Fact
Only people after D&C can get Asherman syndrome	Other causes include infection and other uterine surgeries
It always leads to permanent infertility	Many people regain fertility with prompt, effective treatment
Once treated, it never comes back	Recurrence is possible, especially after severe cases
You can always diagnose it with ultrasound alone	Hysteroscopy is needed for definitive diagnosis and treatment
All intrauterine adhesions cause symptoms	Some adhesions are asymptomatic and only found during fertility workup
Asherman syndrome is untreatable	Advanced hysteroscopic surgery has made many cases treatable and improved outcomes for people trying to conceive

Frequently Asked Questions About Asherman Syndrome

What does Asherman syndrome mean in fertility?

Asherman syndrome is a condition where scar tissue forms inside the uterus, which can decrease fertility by blocking the uterine cavity or preventing the endometrium from supporting implantation. In fertility, it is significant because it can prevent conception or raise miscarriage risk until treated.

What are the main causes of Asherman syndrome?

The most common cause is trauma to the uterine lining after procedures such as D&C following miscarriage, abortion, or birth. Other causes include post-surgical infection, other uterine surgeries, and, less commonly, pelvic tuberculosis in some global regions.

What are typical symptoms of Asherman syndrome?

Symptoms include lighter periods or no periods, pelvic pain, infertility, and sometimes repeated pregnancy losses. Some people do not notice symptoms and are only diagnosed during fertility investigations.

How is Asherman syndrome diagnosed?

The diagnosis is typically confirmed by hysteroscopy, which allows direct visualization and sometimes simultaneous treatment. Preliminary tests (ultrasound, HSG, or saline sonogram) can suggest but not definitively diagnose intrauterine adhesions.

When should Asherman syndrome be suspected?

Suspect Asherman syndrome if there is a history of uterine surgery (e.g., D&C), especially with a new onset of absent or scant periods or infertility in someone who previously had normal cycles.

How does Asherman syndrome affect fertility?

Scar tissue can block sperm from reaching the egg, prevent embryo implantation, disrupt menstrual cycles, or create an environment unsuitable for pregnancy, making conception difficult and increasing the risk of miscarriage or complications.

What is hysteroscopic adhesiolysis?

It is a minimally invasive surgical procedure where a specialist inserts a camera and instruments through the cervix into the uterus to visualize and remove adhesions. This procedure restores the normal uterine lining when possible.

Are there medical treatments for Asherman syndrome?

Surgery (hysteroscopic adhesiolysis) is the main treatment. Postoperative estrogen therapy may help heal the endometrial lining and prevent re-adhesion; antibiotics are used if infection is present.

Does Asherman syndrome come back after treatment?

Recurrence can occur, especially with severe cases or if the underlying cause persists, but recurrence rates are minimized with careful management and preventive strategies.

What is the success rate of fertility treatment after Asherman syndrome?

Outcomes vary: up to 80% of mild to moderate cases will resume menstruation and many will conceive naturally or with fertility treatments after complete removal of adhesions.

Can IVF be used if someone has Asherman syndrome?

IVF is sometimes pursued if the uterus is restored but conception has not occurred naturally. However, if the endometrial lining remains thin or scarred, IVF outcomes may still be compromised.

Can Asherman syndrome be prevented?

Prevention is not always possible, but minimizing unnecessary uterine procedures and promptly treating infections reduces the risk. When D&C is required, using gentle techniques and treating infections beforehand can help.

What does recovery from hysteroscopic adhesiolysis involve?

Most people recover quickly, with a short period of cramping or spotting. Estrogen therapy or a temporary intrauterine device may be recommended for healing, with follow-up to ensure adhesions have not recurred.

Is Asherman syndrome painful or dangerous?

It can cause cyclical pelvic pain and, in rare cases, contribute to dangerous pregnancy complications like abnormal placental implantation. Timely diagnosis and care can reduce risks.

What should I ask my doctor if I suspect Asherman syndrome?

Key questions include: "Could my symptoms be due to uterine scarring?", "Should I have a hysteroscopy?", "What are my treatment options and recovery times?", and "How will this affect my fertility plans?"

Does Asherman syndrome affect everyone equally?

No; individuals differ by type and extent of adhesions, underlying cause, and response to treatment. Personalized care from a fertility specialist is essential.

Can people with Asherman syndrome get pregnant?

Yes, many people conceive after treatment, especially those with mild or moderate adhesions. Severe cases may require repeated intervention and, rarely, gestational surrogacy if the uterine environment remains unsuitable.

Does insurance cover Asherman syndrome treatment?

Coverage varies by policy and region. Hysteroscopy may be considered a medically necessary procedure, but always check with your insurance provider.

Are there long-term effects after successful treatment?

Most people can expect good outcomes in mild cases. However, there may be increased surveillance in pregnancy and a higher risk for some complications even after successful treatment.

When to Consult a Specialist

People experiencing a change in menstrual patterns, persistent pelvic pain, repeated pregnancy losses, or inability to conceive—especially after uterine surgery or infection—should seek evaluation with a reproductive endocrinologist and infertility specialist (REI). Early diagnosis and intervention lead to better outcomes.

Obstetrician/Gynecologist (OB/GYN): For initial workup and referral.
Reproductive Endocrinologist (REI): For advanced fertility evaluation and surgical management.
Urologist/Andrologist: If male-factor infertility is suspected in parallel.
Mental health support: Fertility challenges can impact emotional wellbeing; support is encouraged.

References and Further Reading

March CM. Asherman's syndrome. Obstetrics & Gynecology Clinics of North America
Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertil Steril
Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome—One century later. Fertil Steril
Royal College of Obstetricians and Gynaecologists (RCOG). The management of Asherman’s syndrome. RCOG: Green-Top Guideline
Practice Committee of the American Society for Reproductive Medicine. Uterine factors affecting reproduction. Fertil Steril
Pabuccu R, Onalan G. Asherman syndrome and infertility treatment: current perspectives. Int J Womens Health
World Health Organization. Uterine factors and infertility. WHO
National Institutes of Health (NIH). Intrauterine adhesions (Asherman's syndrome) NIH MedlinePlus
AAGL Practice Report. Practice guidelines for management of intrauterine adhesions. AAGL

Disclaimer

This article is for informational and educational purposes only and does not constitute medical or mental health advice. It is not a substitute for speaking with a qualified healthcare provider, licensed therapist, or other professional who can consider your individual situation.